Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial. (Q38408393)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 July 2015

Language	Label	Description	Also known as
English	Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.	scientific article published on 08 July 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

tuberous sclerosis

1 reference

based on heuristic

inferred from title

tuberous sclerosis 1

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Elena Dmitrievna Belousova

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Bernard A. Zonnenberg

4

object named as

Bernard A Zonnenberg

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

John Christopher Kingswood

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Elżbieta Radzikowska

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Michael Frost

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Matthias Sauter

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Norio Nonomura

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Susanne Brakemeier

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Petrus J de Vries

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Noah Berkowitz

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sara Miao

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Scott Segal

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Severine Peyrard

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

0 references

publication date

8 July 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

111-119

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Hereditary neuroendocrine tumors of the gastroenteropancreatic system

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

The pathogenesis and imaging of the tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Tuberous sclerosis complex: tumors and tumorigenesis.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Identification and characterization of the tuberous sclerosis gene on chromosome 16

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Tuberous sclerosis complex: neurological, renal and pulmonary manifestations

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

A cross sectional study of renal involvement in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Renal angiomyolipomata.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Management of renal angiomyolipoma: analysis of 15 cases.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

A case of tuberous sclerosis complex that progressed to end-stage renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Causes of Death in Patients With Tuberous Sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Lymphangioleiomyomatosis - a wolf in sheep's clothing.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Angiomyolipoma have common mutations in TSC2 but no other common genetic events

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

National Institutes of Health consensus conference: tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

The role of partial nephrectomy for the management of sporadic renal angiomyolipoma

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

The role of therapeutic monitoring of everolimus in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Analysis of lymphocyte activation and proliferation by video microscopy and digital imaging.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Inhibition of MTOR disrupts autophagic flux in podocytes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

How does proteinuria cause progressive renal damage?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Relation between kidney function, proteinuria, and adverse outcomes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV249

21 January 2018

Identifiers

10.1093/NDT/GFV249

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156073%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38408393&oldid=2068742516"